Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA385732
Max Phase: Preclinical
Molecular Formula: C9H17N3O2
Molecular Weight: 199.25
Molecule Type: Small molecule
Associated Items:
ID: ALA385732
Max Phase: Preclinical
Molecular Formula: C9H17N3O2
Molecular Weight: 199.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)NCN(C)C1=O
Standard InChI: InChI=1S/C9H17N3O2/c1-6(2)4-7-8(13)12(3)5-10-9(14)11-7/h6-7H,4-5H2,1-3H3,(H2,10,11,14)/t7-/m0/s1
Standard InChI Key: PPLDCOQCIXMKCL-ZETCQYMHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 199.25 | Molecular Weight (Monoisotopic): 199.1321 | AlogP: 0.13 | #Rotatable Bonds: 2 |
Polar Surface Area: 61.44 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.48 | CX Basic pKa: | CX LogP: -0.04 | CX LogD: -0.04 |
Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.66 | Np Likeness Score: 0.48 |
1. Muller P, Lena G, Boilard E, Bezzine S, Lambeau G, Guichard G, Rognan D.. (2006) In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors., 49 (23): [PMID:17154507] [10.1021/jm0606589] |
Source(1):